Clinical Trial

Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This real-world study tries to collect data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable liver metastases from Metastatic Liver Tumors From Primary Colorectal Cancer (mCRC) refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the safe and appropriate use of SIR-Spheres in China.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-09.
Trial Details
NCT Number NCT06079242
Lead Sponsor GrandPharma (China) Co., Ltd.
Conditions Colorectal Neoplasms
Enrollment 200 participants
Start Date 2023-10-15
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2023-10-13